Sophia Lunt
Assistant Professor
The Lunt Lab focuses on understanding the role of metabolism in supporting cancer proliferation, heterogeneity, and metastasis.
Get in touchBiography
The Lunt Lab focuses on understanding the role of metabolism in supporting cancer proliferation, heterogeneity, and metastasis. We combine powerful mass spectrometry, cell biology, genetic models of cancer, and fluorescent agents to investigate alterations in this complex disease. We aim to rationally design more effective, personalized therapies for cancer based on metabolic targeting.
Read MoreEducation
MIT: Postdoc, Cancer Biology | 2015
Princeton University: Ph.D., Chemistry | 2010
Lebanon Valley College: B.S., Chemistry | 2005
Selected Press
New Joint Research Merges Solar Power Research and Cancer Treatments
BioSpace | 2019-10-28
Michigan State University researchers Sophia Lunt and Richard Lunt, a married couple, work in different departments, but have found a common ground that could lead to cancer diagnostics and therapies.
Can solar technology kill cancer cells?
MSU Today | 2019-10-25
Scientific breakthroughs don’t always happen in labs. For Sophia and Richard Lunt, Michigan State University researchers, many of their breakthroughs happen during neighborhood walks.
Sophia Lunt Traces the Effect of Metabolism on Cancer Metastasis
The Scientist | 2019-04-01
Sophia Lunt’s career in cancer research started with soap. “Soap is both polar and nonpolar, so it binds to nonpolar grease and also to polar water when you go to wash it away,” the Michigan State University chemist says, recalling a high school science lesson. “I thought that was really cool and wanted to learn more about molecules.”
New Inventor Spotlight: Sophia Lunt
Michigan State University: Innovation Center | 2018-08-30
An assistant professor in the Department of Biochemistry and Molecular Biology at Michigan State University since 2016, Dr. Sophia Lunt’s research focuses on investigating metabolic regulation in cancer and aims to use metabolic targeting to design effective, personalized therapies for the complex disease
Media Assets
